Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VHH domain

Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VHH domain

US Patent 11897921 · Granted Feb 13, 2024

Estimated economic value: $431,747,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant gp120 protein with V1-loop deletion2024
Compositions and methods for treating and preventing autoimmune induced cardiac 2023
Inhibitors of CaMKK2 and uses of same2022
Highly immunogenic peptides derived from the human immunodeficiency virus V2 reg2018
Quantifying local inflammatory activity and its use to predict disease progressi2018
Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors2018
Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface env2017
Methods and agents for modulating protocadherin-18 activity2017
Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-12017
Treatment methods using atoxic neurotoxin derivatives2016
Treatment methods using atoxic neurotoxin derivatives2016
Treatment methods using atoxic neurotoxin derivatives2016